These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 3791617)

  • 21. Effect of the new nitrate ester ITF 296 on coronary and systemic hemodynamics in the conscious dog: comparison with nitroglycerin and nicorandil.
    Ueno A; Bergamaschi M; Gromo G; Nonaka K; Mizrahi J
    J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S13-20. PubMed ID: 8839221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacological analysis of a disorder in the mechanisms of coronary vessel reactivity in an experimental model of coronary insufficiency].
    Lysenko LT; Trubetskoĭ AV
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1981; 4(2):74-82. PubMed ID: 7317162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydralazine dilates large epicardial coronary arteries in conscious dogs through an endothelium-independent mechanism.
    Drieu la Rochelle C; Dubois-Randé JL; Hittinger L; Richard V; Berdeaux A; Giudicelli JF
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):315-8. PubMed ID: 7511763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of furyl-dihydropyridine I on coronary collateral circulation in myocardial infarction of dogs].
    Jia MJ; Chen SL; Liao YL; Liu DQ; Li LS; Zhao NP
    Zhongguo Yao Li Xue Bao; 1994 Sep; 15(5):462-5. PubMed ID: 7717077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Underlying mechanism of favorable effect of Ca++-antagonists on conduction delay observed in ischemic myocardium (author's transl)].
    Nakaya H
    Hokkaido Igaku Zasshi; 1981 May; 56(3):335-45. PubMed ID: 7319455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The effect of batroxobin on coronary segmental resistance and coronary blood flow in acute myocardial ischemic dogs].
    Gao F; Sun CK; Pei JM; Wang YM; Li Y; Niu GB; Zang YM
    Yao Xue Xue Bao; 1996; 31(10):727-31. PubMed ID: 9863238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The effects of nitroglycerin on coronary blood flow (author's transl)].
    Giudicelli JF; Berdeaux A
    Nouv Presse Med; 1980 Sep; 9(34 Suppl):2385-9. PubMed ID: 6775288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Difference in site and time course of coronary dilating effects of trapidil, nitroglycerin and dipyridamole in anesthetized dogs.
    Noguchi K; Tomoike H; Ootsubo H; Sakai K; Nakamura M
    J Pharmacol Exp Ther; 1981 Dec; 219(3):809-14. PubMed ID: 6795344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Silent myocardial ischemia and nitrates].
    Palma Gámiz JL
    Ann Cardiol Angeiol (Paris); 1997; 46(7):431-40. PubMed ID: 9452778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term changes in the response of conductance and resistance coronary vessels to endothelium-dependent and independent vasodilators. A double-blind placebo-controlled study of the effect of a 6-month treatment with cilazapril.
    Di Mario C; Strikwerda S; Gil R; Azar A; Rames A; Serruys PW
    Ital Heart J; 2000 Oct; 1(10):674-83. PubMed ID: 11061364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Combined therapy with glycosides and Ca++-antagonistic agents (author's transl)].
    Fleckenstein A; Fleckenstein-Grün G
    Arzneimittelforschung; 1977; 27(3a):736-42. PubMed ID: 577452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beneficial actions of nitrates in cardiovascular disease.
    Abrams J
    Am J Cardiol; 1996 May; 77(13):31C-7C. PubMed ID: 8638524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of exercise-induced coronary vasomotion on anti-ischemic therapy.
    Kaufmann PA; Mandinov L; Seiler C; Hess OM
    Coron Artery Dis; 2000 Jun; 11(4):363-9. PubMed ID: 10860181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response of normal and diseased epicardial coronary arteries to vasoactive drugs: quantitative arteriographic studies.
    Brown BG
    Am J Cardiol; 1985 Sep; 56(9):23E-29E. PubMed ID: 3901724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diameter changes of epicardial coronary arteries and coronary stenoses after intracoronary application of SIN 1, a molsidomine metabolite].
    Schulz W; Wendt T; Scherer D; Kober G
    Z Kardiol; 1983 Jul; 72(7):404-9. PubMed ID: 6613236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Principles and rules of the use of nitrates].
    Garcia Moll M
    Ann Cardiol Angeiol (Paris); 1997; 46(7):399-405. PubMed ID: 9452773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition by nitroglycerin of canine platelet aggregation and cyclic flow reductions in stenosed coronary arteries.
    Tanaka T; Morishima Y; Watanabe K; Takahashi M; Shibano T
    Methods Find Exp Clin Pharmacol; 1995 Dec; 17(10):693-700. PubMed ID: 9053590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacological basis of therapy with molsidomine].
    Bassenge E
    Herz; 1982 Oct; 7(5):296-306. PubMed ID: 6897544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glibenclamide-induced oscillation of canine coronary artery is independent of myocardial ischemia.
    Nakae I; Quan L; Sugimoto Y; Tsutamoto T; Kinoshita M
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):473-9. PubMed ID: 7515993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coronary dilation with nitrocompounds and calcium antagonists.
    Jost S; Rafflenbeul W; Lichtlen PR
    Z Kardiol; 1990; 79 Suppl 3():113-20. PubMed ID: 2099034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.